A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401

Clinical trial NCT01627002 · TERMINATED

Trial details

NCT number: NCT01627002
Sponsor: ProtAffin Biotechnologie AG
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2012-05-01
Primary completion: 2013-04-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.